HTG Molecular Diagnostics: Thomas Dubensky
Aug 24, 2022
HTG Molecular Diagnostics has appointed Thomas Dubensky to its board of directors. Dubensky was the founding CEO of Tempest Therapeutics and currently serves as president of that company. He has also previously served as CSO of Aduro Biotech, Immune Design, and Anza Therapeutics, which he also cofounded.